Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119993) titled 'Building Resilient Futures: Fostering Rural Adolescents' Positive Develo... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119996) titled 'The Role and Mechanism of Type I Collagen Homotrimer in Microvascular In... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120003) titled 'Clinical study of artificial intelligence combined with 3D printing tech... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2500100984) titled 'Repetitive Transcranial Magnetic Stimulation to Prevent Postoperative De... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (KCT0011688) titled 'Robot-assisted Rehabilitation after total knee arthroplasty -randomized contro... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (KCT0011687) titled 'Effects of Korean Red Ginseng Intake on Uterine Fibroid Size and Hormonal Prof... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470801) titled 'Incidence and Risk Factors of Intraoperative Hypothermia in Adult Patients Af... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471321) titled 'Parental EMDR Therapy After a Baby's Stay in the NICU' on March 6. Study Typ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471932) titled 'A Study of LAD106 in Healthy Adult Participants' on March 6. Study Type: Int... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470840) titled 'SBRT, Anlotinib and Benmelstobart for RCC' on March 6. Study Type: Intervent... Read More